Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 113 publications
Safety and Efficacy of Vascular Embolization with N-Butyl Cyanoacrylate-Lipiodol Mixture: A Systematic Literature Review and Meta-Analysis of 8996 Patients.
Journal: Cardiovascular and interventional radiology
Published: March 22, 2026
Glue (n-Butyl Cyanoacrylate) for Prostate Artery Embolization: Development of a Glue Penetration Score and Association with Clinical Outcomes.
Journal: Journal of vascular and interventional radiology : JVIR
Published: June 26, 2025
Predicting Early Outcomes of Prostatic Artery Embolization Using n-Butyl Cyanoacrylate Liquid Embolic Agent: A Machine Learning Study.
Journal: Diagnostics (Basel, Switzerland)
Published: April 19, 2025
Multiparametric MRI for Diagnosing Clinically Significant Portal Hypertension and Predicting Liver Decompensation.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 25, 2025
Anomalous Origins of the Prostatic Artery from the Inferior Mesenteric Artery Identified during Prostatic Artery Embolization.
Journal: Journal of vascular and interventional radiology : JVIR
Published: January 25, 2025
Histopathologic Response and Oncologic Outcomes after Segmental and Subsegmental Transarterial Chemoembolization and Radioembolization for Hepatocellular Carcinoma.
Journal: Journal of vascular and interventional radiology : JVIR
Published: October 23, 2024
Splanchnic hemodynamic parameters measured with 4D flow MRI can diagnose severe portal hypertension.
Splanchnic hemodynamic parameters measured with 4D flow MRI can diagnose severe portal hypertension.
Journal: European radiology
Published: October 16, 2024
Evaluation of Vessel Tracking Software for Prostatic Artery Embolization.
Journal: Cardiovascular and interventional radiology
Published: February 06, 2024
Early Outcomes of Prostatic Artery Embolization using n-Butyl Cyanoacrylate Liquid Embolic Agent: A Safety and Feasibility Study.
Journal: Journal of vascular and interventional radiology : JVIR
Published: November 30, 2023
Radioembolization plus Immune Checkpoint Inhibitor Therapy Compared with Radioembolization plus Tyrosine Kinase Inhibitor Therapy for the Treatment of Hepatocellular Carcinoma.
Journal: Journal of vascular and interventional radiology : JVIR
Published: June 22, 2023
Last Updated: 09/26/2026